Tags: Closures and Mergersclosures-and-mergersUniversity of Cambridge\Medical research Council Toxicology Unit\mRNA therapeutics\
| Profile | Contacts | Recent Articles on Subject | |
|---|---|---|---|
| 1 | James Woodford New Scientist Ocean Correspondent. South Coast, New South Wales | ||
| 2 | Ben Dickson VentureBeat Software Engineer, Tech analyst. Founder at BD Tech Talks. In a private namespace | DeepMind’s Talker-Reasoner framework brings System 2 thinking to AI agents - about 1 month ago Imperial College London, DeepMind introduce embodied agents that learn with less data - 4 months ago Meta researchers distill System 2 thinking into LLMs, improving performance on complex reasoning - 4 months ago UC Berkeley’s transformer-based robot control system generalizes to unseen environments - 11 months ago Here is how far we are to achieving AGI, according to DeepMind - about 1 year ago | |
| 3 | Greg Laub MedPage Today Director of Video at MedPage Today. Screenwriter, previous managing editor. | ||
| 4 | Will Knight Wired Writes about AI. Cambridge, Massachusetts | ||
| 5 | Katrina Krämer Nature Science journalist. Cambridge, UK | AI & robotics briefing: LLMs harbour hidden racism - 8 months ago | |
| 6 | Michael Nuñez VentureBeat Editorial Director at VentureBeat. San Francisco | ||
| 7 | Emily Mullin Wired Staff writer at WIRED. Covers biotechnology. Fall 2021 fellow. Pittsburgh, Pennsylvania | China Has a Controversial Plan for Brain-Computer Interfaces - 7 months ago | |
| 8 | John Pinching PharmaTimes Next-gen biopharma company. La Jolla, California | Alex Livingstone-Learmonth - 7 months ago | |
| 9 | The Conversation Science Alert Science news. Official account. Australia | ||
| 10 | Keumars Afifi-Sabet Live Science Technology editor @LiveScience. Sarcasm specialist. London |